Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMP.L Share News (AMP)

  • There is currently no data for AMP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Amphion Has No Obligations To Lender After Polarean Stake Sale

Fri, 18th Oct 2019 09:44

(Alliance News) - Amphion Innovations PLC on Friday said it has settled its loan facility with an undisclosed lender and now has no outstanding obligations.

The developer of medical, life science, and technology businesses on Friday last week had sold its entire holding in Polarean Imaging PLC for USD2.6 million.

Amphion's interest in Polarean was pledged as security against a loan facility and the shares were sold as part of this security arrangement.

Looking ahead, the company said it remains "highly cash constrained".

Amphion shares remain suspended due to the failure to publish audited financial statements for 2018 by June 30. Polarean shares were trading 3.5% higher in London on Friday at 23.28 pence each.

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
10 Sep 2015 09:23

WINNERS & LOSERS SUMMARY: Dixons And Next Up But Morrisons Sinks

Read more
10 Sep 2015 07:12

Amphion Innovations' DataTern Gets Favourable Patent Dispute Ruling

Read more
3 Sep 2015 09:42

WINNERS & LOSERS SUMMARY: M&A Speculation And Upgrade Boost Morrisons

Read more
3 Sep 2015 07:46

Amphion Innovations Sees "Dramatic Rise" In Value On Motif Bio Float

Read more
23 Jun 2015 09:28

Amphion Innovations Confident After Motif IPO, 2014 Asset Value Fall

Read more
5 Jun 2015 10:59

LONDON MIDDAY BRIEFING: Vodafone In Asset Swap Talks With Liberty

Read more
5 Jun 2015 10:27

WINNERS & LOSERS: Halfords Rides Higher As Sales Hit GBP1 Billion

Read more
5 Jun 2015 07:11

Amphion Innovations Raises GBP1.5 Million In Discounted Issue (ALLISS)

Read more
15 Apr 2015 07:31

LONDON MORNING BRIEFING: Next And Burberry Shares In Fashion

Read more
15 Apr 2015 07:10

Amphion Shares Up As Motif Bio Gets US FDA Approval For Iclaprim Trial

Read more
7 Apr 2015 08:01

Amphion Innovations Gets GBP580,842 From Exercised Warrants (ALLISS)

Read more
2 Apr 2015 11:46

Motif Bio makes AIM debut, seeks approval for Iclaprim treatment

Clinical stage biopharmaceutical group Motif Bio began trading on AIM on Thursday, after raising £2.8m in its initial public offering. The group, whose 44.09% of issued equity is owned by Amphion, placed shares at 20p each, said it had 64,238,442 ordinary shares in issue and a market capitalisation

Read more
2 Apr 2015 08:19

BCA Marketplace, Marshall Motor And Motif Bio Begin Trading (ALLIPO)

Read more
24 Mar 2015 15:41

Amphion Issues 1.3 Million Shares At GBP0.0266 To YA Global Master (ALLISS)

Read more
20 Mar 2015 12:20

LONDON MIDDAY BRIEFING: TSB Banking To Go The Way Of Abbey National

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.